private:cmcbiologics
|
24162
|
May 23rd, 2019 12:00AM
|
CMC Biologics
|
8.9K
|
1.00
|
Open
|
Biotechnology
|
May 23rd, 2019 03:13PM
|
May 23rd, 2019 03:13PM
|
PLEASE VISIT US AT OUR AGC BIOLOGICS PAGE: https://www.linkedin.com/company/18445366/
AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO), with a relentless c
|
Open
|
Mammalian Cell Line Development, Microbial Cell Line Development, Upstream Process Development, Downstream Process Development, Analytical Development, Formulation Development, cGMP Manufacturing, GMP Stability Studies and Storage, The CHEF1 expression
|
Open
|
22021 20th Avenue SE
|
Bothell
|
WA
|
US
|
98021
|
|
CMC Biologics
|
|
Health Care Equipment & Services
|
private:cmcbiologics
|
24162
|
Mar 14th, 2018 12:00AM
|
CMC Biologics
|
8.4K
|
583.00
|
Open
|
Biotechnology
|
Mar 14th, 2018 07:17PM
|
Mar 14th, 2018 07:17PM
|
|
Open
|
|
|
|
|
|
|
|
|
CMC Biologics
|
|
Health Care Equipment & Services
|
private:cmcbiologics
|
24162
|
Feb 17th, 2018 12:00AM
|
CMC Biologics
|
7.9K
|
647.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
CMC Biologics (CMC), a wholly-owned subsidiary of Asahi Glass Company (AGC), is one of the industry leading CMOs in reliability, technical excellence, and quality — Right and On Time.
With three facilities in the USA and Europe, the Company provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and commercial production.
The Company’s wide range of integrated services includes cell line development, bioprocess development, formulation development, and comprehensive analytical testing.
Through the Company’s PROVEO™ Alliance, they provide clients a fully realized and configurable antibody drug conjugate (ADC) solution—from MAb process development and manufacture, to payload manufacture and conjugation, and on through fill, finish, labeling and packaging.
Clients can also benefit from CMC Biologics’ proprietary CHEF1® expression system for mammalian production. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes.
Visit www.cmcbio.com to learn why CMC Biologics is a World Leader in process development and contract manufacturing.
|
|
|
|
|
|
|
|
|
|
CMC Biologics
|
|
Health Care Equipment & Services
|
private:cmcbiologics
|
24162
|
Feb 16th, 2018 12:00AM
|
CMC Biologics
|
7.9K
|
647.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
CMC Biologics (CMC), a wholly-owned subsidiary of Asahi Glass Company (AGC), is one of the industry leading CMOs in reliability, technical excellence, and quality — Right and On Time.
With three facilities in the USA and Europe, the Company provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and commercial production.
The Company’s wide range of integrated services includes cell line development, bioprocess development, formulation development, and comprehensive analytical testing.
Through the Company’s PROVEO™ Alliance, they provide clients a fully realized and configurable antibody drug conjugate (ADC) solution—from MAb process development and manufacture, to payload manufacture and conjugation, and on through fill, finish, labeling and packaging.
Clients can also benefit from CMC Biologics’ proprietary CHEF1® expression system for mammalian production. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes.
Visit www.cmcbio.com to learn why CMC Biologics is a World Leader in process development and contract manufacturing.
|
|
|
|
|
|
|
|
|
|
CMC Biologics
|
|
Health Care Equipment & Services
|
private:cmcbiologics
|
24162
|
Feb 15th, 2018 12:00AM
|
CMC Biologics
|
7.9K
|
647.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
CMC Biologics (CMC), a wholly-owned subsidiary of Asahi Glass Company (AGC), is one of the industry leading CMOs in reliability, technical excellence, and quality — Right and On Time.
With three facilities in the USA and Europe, the Company provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and commercial production.
The Company’s wide range of integrated services includes cell line development, bioprocess development, formulation development, and comprehensive analytical testing.
Through the Company’s PROVEO™ Alliance, they provide clients a fully realized and configurable antibody drug conjugate (ADC) solution—from MAb process development and manufacture, to payload manufacture and conjugation, and on through fill, finish, labeling and packaging.
Clients can also benefit from CMC Biologics’ proprietary CHEF1® expression system for mammalian production. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes.
Visit www.cmcbio.com to learn why CMC Biologics is a World Leader in process development and contract manufacturing.
|
|
|
|
|
|
|
|
|
|
CMC Biologics
|
|
Health Care Equipment & Services
|
private:cmcbiologics
|
24162
|
Feb 14th, 2018 12:00AM
|
CMC Biologics
|
7.9K
|
647.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
CMC Biologics (CMC), a wholly-owned subsidiary of Asahi Glass Company (AGC), is one of the industry leading CMOs in reliability, technical excellence, and quality — Right and On Time.
With three facilities in the USA and Europe, the Company provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and commercial production.
The Company’s wide range of integrated services includes cell line development, bioprocess development, formulation development, and comprehensive analytical testing.
Through the Company’s PROVEO™ Alliance, they provide clients a fully realized and configurable antibody drug conjugate (ADC) solution—from MAb process development and manufacture, to payload manufacture and conjugation, and on through fill, finish, labeling and packaging.
Clients can also benefit from CMC Biologics’ proprietary CHEF1® expression system for mammalian production. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes.
Visit www.cmcbio.com to learn why CMC Biologics is a World Leader in process development and contract manufacturing.
|
|
|
|
|
|
|
|
|
|
CMC Biologics
|
|
Health Care Equipment & Services
|
private:cmcbiologics
|
24162
|
Feb 13th, 2018 12:00AM
|
CMC Biologics
|
7.9K
|
647.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
CMC Biologics (CMC), a wholly-owned subsidiary of Asahi Glass Company (AGC), is one of the industry leading CMOs in reliability, technical excellence, and quality — Right and On Time.
With three facilities in the USA and Europe, the Company provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and commercial production.
The Company’s wide range of integrated services includes cell line development, bioprocess development, formulation development, and comprehensive analytical testing.
Through the Company’s PROVEO™ Alliance, they provide clients a fully realized and configurable antibody drug conjugate (ADC) solution—from MAb process development and manufacture, to payload manufacture and conjugation, and on through fill, finish, labeling and packaging.
Clients can also benefit from CMC Biologics’ proprietary CHEF1® expression system for mammalian production. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes.
Visit www.cmcbio.com to learn why CMC Biologics is a World Leader in process development and contract manufacturing.
|
|
|
|
|
|
|
|
|
|
CMC Biologics
|
|
Health Care Equipment & Services
|
private:cmcbiologics
|
24162
|
Feb 12th, 2018 12:00AM
|
CMC Biologics
|
7.9K
|
647.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
CMC Biologics (CMC), a wholly-owned subsidiary of Asahi Glass Company (AGC), is one of the industry leading CMOs in reliability, technical excellence, and quality — Right and On Time.
With three facilities in the USA and Europe, the Company provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and commercial production.
The Company’s wide range of integrated services includes cell line development, bioprocess development, formulation development, and comprehensive analytical testing.
Through the Company’s PROVEO™ Alliance, they provide clients a fully realized and configurable antibody drug conjugate (ADC) solution—from MAb process development and manufacture, to payload manufacture and conjugation, and on through fill, finish, labeling and packaging.
Clients can also benefit from CMC Biologics’ proprietary CHEF1® expression system for mammalian production. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes.
Visit www.cmcbio.com to learn why CMC Biologics is a World Leader in process development and contract manufacturing.
|
|
|
|
|
|
|
|
|
|
CMC Biologics
|
|
Health Care Equipment & Services
|
private:cmcbiologics
|
24162
|
Feb 11th, 2018 12:00AM
|
CMC Biologics
|
7.9K
|
647.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
CMC Biologics (CMC), a wholly-owned subsidiary of Asahi Glass Company (AGC), is one of the industry leading CMOs in reliability, technical excellence, and quality — Right and On Time.
With three facilities in the USA and Europe, the Company provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and commercial production.
The Company’s wide range of integrated services includes cell line development, bioprocess development, formulation development, and comprehensive analytical testing.
Through the Company’s PROVEO™ Alliance, they provide clients a fully realized and configurable antibody drug conjugate (ADC) solution—from MAb process development and manufacture, to payload manufacture and conjugation, and on through fill, finish, labeling and packaging.
Clients can also benefit from CMC Biologics’ proprietary CHEF1® expression system for mammalian production. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes.
Visit www.cmcbio.com to learn why CMC Biologics is a World Leader in process development and contract manufacturing.
|
|
|
|
|
|
|
|
|
|
CMC Biologics
|
|
Health Care Equipment & Services
|
private:cmcbiologics
|
24162
|
Feb 10th, 2018 12:00AM
|
CMC Biologics
|
7.9K
|
647.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
CMC Biologics (CMC), a wholly-owned subsidiary of Asahi Glass Company (AGC), is one of the industry leading CMOs in reliability, technical excellence, and quality — Right and On Time.
With three facilities in the USA and Europe, the Company provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and commercial production.
The Company’s wide range of integrated services includes cell line development, bioprocess development, formulation development, and comprehensive analytical testing.
Through the Company’s PROVEO™ Alliance, they provide clients a fully realized and configurable antibody drug conjugate (ADC) solution—from MAb process development and manufacture, to payload manufacture and conjugation, and on through fill, finish, labeling and packaging.
Clients can also benefit from CMC Biologics’ proprietary CHEF1® expression system for mammalian production. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes.
Visit www.cmcbio.com to learn why CMC Biologics is a World Leader in process development and contract manufacturing.
|
|
|
|
|
|
|
|
|
|
CMC Biologics
|
|
Health Care Equipment & Services
|